India has the highest prevalence of diabetes globally, with an estimated 77 million people living with the condition and an expected 134 million cases by 2045
India-Sweden Healthcare Innovation Centre in collaboration with AIIMS Jodhpur and AstraZeneca India launches an e-learning Upskilling Program in Diabetes Management for nurses
First advanced hybrid closed-loop insulin pump system in India features automatic insulin delivery, automatic correction boluses, and bluetooth connectivity
The company claims that its Empagliflozin tablets are the most affordable in India
The consultations are virtual and they have launched the Diabetes Reversal Programme to address the issue
The new formulation features what Abbott calls a “triple care system,” anchored by a blend of nutrients aimed at supporting blood sugar control and metabolic health
Agreements mark a major victory in the President’s long-term pledge to lower prescription drug costs for Americans
This predictive technology empowers people with diabetes to take preventive action before complications arise
Now integrates with Abbott’s instinct sensor and approved for type 2 diabetes
Over 100 million cartridges of rh-insulin supplied to Malaysian health ministry; 345,000+ patients served
Subscribe To Our Newsletter & Stay Updated
